June 10, 2014 / 3:18 PM / 3 years ago

BRIEF-Allergan CEO says investors must question Valeant's "mishmash" financial reporting

June 10 (Reuters) - Allergan: * Allergan CEO says he's an "endurance player," prepared for long

battle with Valeant * Allergan CEO says first priority among its shareholders is for company to

make strategic acquisitions * Allergan CEO says Valeant stands alone in industry by failure to disclose

product sales, instead has "mishmash" of reporting buckets * Allergan CEO says company, investors need to question value of Valeant stock

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below